The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Open accessAbstract
Induced pluripotent stem (iPS) cells can be generated from somatic cells by the introduction of Oct3/4 (also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse and in human. The efficiency of this process, however, is low. Pluripotency can be induced without c-Myc, but with even lower efficiency. A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation, but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that OSKM induction activates the p53–p21 pathway25.”
From In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche (2021) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationInduced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Self-citationIn vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R. K., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,732
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Self-citationGeneration of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,056
Self-citationMaherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Plat-E: an efficient and stable system for transient packaging of retroviruses
MORITA, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,003
Pre-mRNA processing factors meet the DNA damage response
Montecucco, A., & Biamonti, G. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00102 · Cited by 69
New insights into p53 functions through its target microRNAs
Liao, J.-M., Cao, B., Zhou, X. Y., & Lu, H. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju018 · Cited by 71
Sang, L., Wu, X., Yan, T., Naren, D., Liu, X., Zheng, X. Y., Zhang, N., Wang, H., Li, Y., & Gong, Y. (2022) · Journal of Cancer · doi:10.7150/jca.60381 · Cited by 69
Cell Reprogramming Requires Silencing of a Core Subset of Polycomb Targets
Fragola, G., Germain, P., Laise, P., Cuomo, A., Blasimme, A., Groß, F., Signaroldi, E., Bucci, G., Sommer, C., Pruneri, G., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003292 · Cited by 74
Methods of induced pluripotent stem cells for clinical application
Seki, T. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.116 · Cited by 69
ArhGAP30 promotes p53 acetylation and function in colorectal cancer
Wang, J., Qian, J., Hu, Y., Kong, X., Chen, H., Shi, Q., Jiang, L., Wu, C., Zou, W., Chen, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms5735 · Cited by 69
Stem Cells in Normal Development and Cancer
D'Angelo, R. C., & Wicha, M. S. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00006-x · Cited by 68
An Insight into Reprogramming Barriers to iPSC Generation
Haridhasapavalan, K. K., Raina, K., Dey, C., Adhikari, P., & Thummer, R. P. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09931-1 · Cited by 70
Madrid, M., Lakshmipathy, U., Zhang, X., Bharti, K., Wall, D. M., Sato, Y., Muschler, G. F., Ting, A. E., Smith, N., Deguchi, S., et al. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.05.022 · Cited by 67
Watarai, H., Fujii, S., Yamada, D., Rybouchkin, A., Sakata, S., Nagata, Y., Iida-Kobayashi, M., Sekine-Kondo, E., Shimizu, K., Shozaki, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42027 · Cited by 67
Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8
Chakravarti, D., Su, X., Cho, M. S., Bui, N. H. B., Coarfa, C., Venkatanarayan, A., Benham, A. L., González, R. E. F., Alana, J., Xiao, W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319743111 · Cited by 67
Tumor suppressors: enhancers or suppressors of regeneration?
Pomerantz, J. H., & Blau, H. M. (2013) · Development · doi:10.1242/dev.084210 · Cited by 68
SOX17 in cellular reprogramming and cancer
Tan, D. S., Holzner, M., Weng, M., Srivastava, Y., & Jauch, R. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.008 · Cited by 67
Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application
Saito, S., Ku, C., Wuputra, K., Pan, J.-B., Lin, C., Lin, Y., Wu, D., & Yokoyama, K. K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050715 · Cited by 66
The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
Arsic, N., Gadéa, G., Lagerqvist, E. L., Busson, M., Cahuzac, N., Brock, C., Hollande, F., Gire, V., Pannequin, J., & Roux, P. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.001 · Cited by 66
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation
Terzian, T., Torchia, E. C., Dai, D., Robinson, S. E., Murao, K., Stiegmann, R. A., Gonzalez, V., Boyle, G. M., Powell, M. B., Pollock, P. M., et al. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00773.x · Cited by 66
Chemical Strategies for Stem Cell Biology and Regenerative Medicine
Zhu, S., Wei, W., & Ding, S. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124715 · Cited by 66
Dppa2/4 Facilitate Epigenetic Remodeling during Reprogramming to Pluripotency
Hernandez, C. C., Wang, Z., Ramazanov, B. R., Tang, Y., Mehta, S. S., Dambrot, C., Lee, Y.-W., Tessema, K. K., Kumar, I., Astudillo, M. G., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.08.001 · Cited by 65
Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
Olivos, D. J., & Mayo, L. D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121982 · Cited by 67
Aarts, M., Georgilis, A., Beniazza, M., Beolchi, P., Banito, A., Carroll, T., Kulisic, M., Kaemena, D. F., Dharmalingam, G., Martin, N., et al. (2017) · Genes & Development · doi:10.1101/gad.297796.117 · Cited by 64
Jung, D., Kim, W., & Williams, D. R. (2013) · ACS Chemical Biology · doi:10.1021/cb400754f · Cited by 66
Rao, R. A., Dhele, N., Cheemadan, S., Ketkar, A. A., Jayandharan, G. R., Palakodeti, D., & Rampalli, S. (2015) · Scientific Reports · doi:10.1038/srep08229 · Cited by 69
Wang, Y., Chen, S., Yan, Z., & Pei, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0264-9 · Cited by 69
Reprogramming: identifying the mechanisms that safeguard cell identity
Brumbaugh, J., Stefano, B. D., & Hochedlinger, K. (2019) · Development · doi:10.1242/dev.182170 · Cited by 66
Concise Review: Dedifferentiation Meets Cancer Development: Proof of Concept for Epigenetic Cancer
Yamada, Y., Haga, H., & Yamada, Y. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0090 · Cited by 64
MicroRNAs in pluripotency, reprogramming and cell fate induction
Lüningschrör, P., Hauser, S., Kaltschmidt, B., & Kaltschmidt, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.025 · Cited by 64
Park, S. J., Yeo, H. C., Kang, N., Kim, H., Lin, J., Ha, H., Vendrell, M., Lee, J., Chandran, Y., Lee, D., et al. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.03.002 · Cited by 65
Wang, Y.-C., Stein, J. W., Lynch, C. L., Tran, H. T. T., Lee, C.-Y., Coleman, R., Hatch, A., Antontsev, V. G., Chy, H. S., O’Brien, C., et al. (2015) · Scientific Reports · doi:10.1038/srep13317 · Cited by 64
Turinetto, V., Orlando, L., & Giachino, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091952 · Cited by 71
Hamasaki, M., Hashizume, Y., Yamada, Y., Katayama, T., Hohjoh, H., Fusaki, N., Nakashima, Y., Furuya, H., Haga, N., Takami, Y., et al. (2012) · Stem Cells · doi:10.1002/stem.1221 · Cited by 63
Yang, C., Chang, K., & Rana, T. M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.002 · Cited by 63
Spontaneous and inherited TP53 genetic alterations
Levine, A. J. (2021) · Oncogene · doi:10.1038/s41388-021-01991-3 · Cited by 67
Mechanisms maintaining genomic integrity in embryonic stem cells and induced pluripotent stem cells
Tichy, E. D. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011107 · Cited by 62
A Cyclic AMP Analog, 8-Br-cAMP, Enhances the Induction of Pluripotency in Human Fibroblast Cells
Wang, Y., & Adjaye, J. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9209-3 · Cited by 62
Induced pluripotent stem cells: what lies beyond the paradigm shift
Cox, J. L., & Rizzino, A. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009267 · Cited by 62
Qian, Y., Chen, Y., Yang, W. K., Fu, J., Cao, J., Ren, Y., Zhu, J., Su, B., Luo, T., Zhao, X., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.042 · Cited by 62
Embryonic Stem Cells or Induced Pluripotent Stem Cells? A DNA Integrity Perspective
Baï, Q., Desprat, R., Klein, B., Lemaı̂tre, J.-M., & Vos, J. D. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020003 · Cited by 68
Telomere rejuvenation during nuclear reprogramming
Marión, R. M., & Blasco, M. A. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.01.005 · Cited by 62
Deng, Y., Liu, Q., Luo, C., Chen, S., Li, X., Wang, C., Liu, Z., Lei, X., Zhang, H., Sun, H., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0018 · Cited by 61
Effect of Dedifferentiation on Time to Mutation Acquisition in Stem Cell-Driven Cancers
Jilkine, A., & Gutenkunst, R. N. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003481 · Cited by 64
Walia, B., Satija, N. K., Tripathi, R. P., & Gangenahalli, G. U. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9279-x · Cited by 62
The p53–PUMA axis suppresses iPSC generation
Li, Y., Feng, H., Gu, H., Lewis, D. W., Yuan, Y., Zhang, L., Yu, H. M., Zhang, P., Cheng, H., Miao, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3174 · Cited by 64
Li, D., Wang, L., Hou, J., Shen, Q., Chen, Q., Wang, X., Du, J., Cai, X., Shan, Y., Zhang, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.001 · Cited by 63
Protein intrinsic disorder and induced pluripotent stem cells
Xue, B., Oldfield, C. J., Van, Y.-Y. J., Dunker, A. K., & Uversky, V. N. (2011) · Molecular BioSystems · doi:10.1039/c1mb05163f · Cited by 60
Martins, A. M., Vunjak‐Novakovic, G., & Reis, R. L. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9487-7 · Cited by 60
Gene-delivery systems for iPS cell generation
Shao, L., & Wu, W.-S. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903455989 · Cited by 63
Gu, Z., Jiang, J., Tan, W., Xia, Y., Cao, H., Meng, Y., Da, Z., Liu, H., & Cheng, C. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/134243 · Cited by 60
Solá, S., Xavier, J. M., dos Santos, D. M., Aranha, M. M., Morgado, A. L., Jepsen, K., & Rodrigues, C. M. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018421 · Cited by 61
Progress and Promise Towards Safe Induced Pluripotent Stem Cells for Therapy
Seifinejad, A., Tabebordbar, M., Baharvand, H., Boyer, L. A., & Salekdeh, G. H. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9121-x · Cited by 59
Human induced pluripotent stem cells—from mechanisms to clinical applications
Drews, K., Józefczuk, J., Prigione, A., & Adjaye, J. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0913-0 · Cited by 59
Le, R., Kou, Z., Jiang, Y., Li, M., Huang, B. S., Liu, W., Li, H., Kou, X., He, W., Rudolph, K. L., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.005 · Cited by 58
One billion years of p53/p63/p73 evolution
Белый, В. А., & Levine, A. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910634106 · Cited by 58
Tied Up in Loops: Positive and Negative Autoregulation of p53Preprint
Lü, X. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000984 · Cited by 58
Babos, K. N., Galloway, K. E., Kisler, K., Zitting, M., Li, Y., Shi, Y., Quintino, B., Chow, R. H.-P., Zloković, B. V., & Ichida, J. K. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.08.005 · Cited by 58
Song, J., Kang, S. M., Kim, E., Kim, C. H., Song, H.-T., & Lee, J. E. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.220 · Cited by 58
RNA-Seq Transcriptome Profiling of Equine Inner Cell Mass and Trophectoderm1
Iqbal, K., Chitwood, J. L., Meyers-Brown, G. A., Roser, J. F., & Ross, P. J. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.113928 · Cited by 57
Gerona‐Navarro, G., Yoel-Rodríguez, Mujtaba, S., Frasca, A., Patel, J. A., Zeng, L., Plotnikov, A. N., Osman, R., & Zhou, M. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107761h · Cited by 57
Defining the Minimal Factors Required for Erythropoiesis through Direct Lineage Conversion
Capellera-Garcia, S., Pulecio, J., Dhulipala, K., Siva, K., Rayon-Estrada, V., Singbrant, S., Sommarin, M. N. E., Walkley, C. R., Soneji, S., Karlsson, G., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.027 · Cited by 63
de Jesus, B. B., Marinho, S. P., Barros, S. A., Sousa‐Franco, A., Alves‐Vale, C., Carvalho, T., & Carmo‐Fonseca, M. (2018) · Nature Communications · doi:10.1038/s41467-017-01921-6 · Cited by 59
p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions
Fujita, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236023 · Cited by 59
Induced Tissue-Specific Stem Cells and Epigenetic Memory in Induced Pluripotent Stem Cells
Noguchi, H., Miyagi‐Shiohira, C., & Nakashima, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040930 · Cited by 56
Li, M., Zhong, A., Wu, Y., Sidharta, M., Beaury, M. W., Zhao, X., Studer, L., & Zhou, T. (2022) · Nature Communications · doi:10.1038/s41467-022-34045-7 · Cited by 57
Zhang, M., Kumar, B., Piao, L., Xie, X., Schmitt, A. C., Arradaza, N., Cippola, M., Old, M. O., Agrawal, A., Ozer, E. K., et al. (2013) · Cancer · doi:10.1002/cncr.28538 · Cited by 56
Concise Review: Culture Mediated Changes in Fate and/or Potency of Stem Cells
Roobrouck, V. D., Vanuytsel, K., & Verfaillie, C. M. (2011) · Stem Cells · doi:10.1002/stem.603 · Cited by 56
BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis
Gauchotte, G., Philippe, C., Lacomme, S., Léotard, B., Wissler, M.-P., Allou, L., Toussaint, B., Klein, M., Vignaud, J.-M., & Bressenot, A. (2011) · Pathology · doi:10.1097/pat.0b013e3283486178 · Cited by 56
Energy Metabolism in Nuclear Reprogramming
Folmes, C. D. L., Nelson, T. J., & Terzic, A. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.87 · Cited by 57
Chistiakov, D. A. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-92 · Cited by 59
Multifaceted role for p53 in pancreatic cancer suppression
Mello, S. S., Flowers, B. M., Mazur, P. K., Lee, J. J., Müller, F., Denny, S. K., Ferreira, S., Hanson, K., Kim, S. K., Greenleaf, W. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211937120 · Cited by 55
Nishino, K., Toyoda, M., Yamazaki‐Inoue, M., Makino, H., Fukawatase, Y., Chikazawa, E., Takahashi, Y., Miyagawa, Y., Okita, H., Kiyokawa, N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013017 · Cited by 55
How microRNAs facilitate reprogramming to pluripotency
Anokye-Danso, F., Snitow, M. E., & Morrisey, E. (2012) · Journal of Cell Science · doi:10.1242/jcs.095968 · Cited by 53
Boué, S., Paramonov, I., Barrero, M. J., & Belmonte, J. C. I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012664 · Cited by 55
Lian, Q., Chow, Y., Esteban, M., Pei, D., & Tse, H.-F. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-05-0269 · Cited by 55
MYC Transcription Factors: Key Regulators Behind Establishment and Maintenance of Pluripotency
Smith, K. N., & Dalton, S. (2010) · Regenerative Medicine · doi:10.2217/rme.10.79 · Cited by 56
Embryonic stem cell-like cells established by culture of adult ovarian cells in mice
Gong, S. P., Lee, S. T., Lee, E. J., Kim, D.-Y., Lee, G., Chi, S., Ryu, B., Lee, C. H., Yum, K. E., Lee, H., et al. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.12.053 · Cited by 55
MYC and the Art of MicroRNA MaintenancePreprint
Psathas, J. N., & Thomas‐Tikhonenko, A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014175 · Cited by 55
Reprogramming and Carcinogenesis—Parallels and Distinctions
Wasik, A. M., Grabarek, J., Pantovic, A., Cieślar‐Pobuda, A., Asgari, H. R., Bundgaard‐Nielsen, C., Rafat, M., Dixon, I., Ghavami, S., & Łoś, M. (2014) · International review of cytology · doi:10.1016/b978-0-12-800097-7.00005-1 · Cited by 54
Fu, X., & Xu, Y. (2012) · Genome Medicine · doi:10.1186/gm354 · Cited by 55
Multifaceted Regulation of Somatic Cell Reprogramming by mRNA Translational Control
Tahmasebi, S., Alain, T., Rajasekhar, V. K., Zhang, J.-P., Prager‐Khoutorsky, M., Khoutorsky, A., Dogan, Y., Gkogkas, C. G., Petroulakis, E., Sylvestre, A., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.005 · Cited by 54
Deng, Z., Du, W. W., Fang, L., Shan, S. W., Qian, J., Lin, J., Qian, W., Ma, J., Rutnam, Z. J., & Yang, B. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.418830 · Cited by 54
The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells
Fong, Y. W., Ho, J. J., Inouye, C. J., & Tjian, R. (2014) · eLife · doi:10.7554/elife.03573 · Cited by 54
Linking Pluripotency Reprogramming and Cancer
Iglesias, J. M., Gumuzio, J., & Martín, Á. G. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0225 · Cited by 53
Mechanistic insights into reprogramming to induced pluripotency
Ho, R., Chronis, C., & Plath, K. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22450 · Cited by 57
p53 orchestrates between normal differentiation and cancer
Rivlin, N., Koifman, G., & Rotter, V. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.006 · Cited by 56
Folmes, C. D. L., Martinez‐Fernandez, A., Faustino, R. S., Yamada, S., Pérez-Terzic, C. M., Nelson, T. J., & Terzic, A. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9431-2 · Cited by 56
Cheng, Z., Ito, S., Nishio, N., Xiao, H., Zhang, R., Suzuki, H., Okawa, Y., Murohara, T., & Isobe, K. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq044 · Cited by 53
Pax3 Stimulates p53 Ubiquitination and Degradation Independent of Transcription
Wang, X. D., Morgan, S. C., & Loeken, M. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029379 · Cited by 53
Turning terminally differentiated skeletal muscle cells into regenerative progenitors
Wang, H., Lööf, S., Borg, P., Nader, G. A., Blau, H. M., & Simon, A. (2015) · Nature Communications · doi:10.1038/ncomms8916 · Cited by 53
Strategies for bringing stem cell-derived dopamine neurons to the clinic
Takahashi, J. B. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.11.004 · Cited by 56
Raya, Á., Rodríguez-Pizà, I., Navarro, S., Richaud‐Patín, Y., Güenechea, G., Sánchez‐Danés, A., Consiglio, A., Bueren, J. A., & Belmonte, J. C. I. (2010) · Nature Protocols · doi:10.1038/nprot.2010.9 · Cited by 52
Artyomov, M. N., Meissner, A., & Chakraborty, A. K. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000785 · Cited by 52
p53 Counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition
Brosh, R., Assia-Alroy, Y., Molchadsky, A., Bornstein, C., Dekel, E., Madar, S., Shetzer, Y., Rivlin, N., Goldfinger, N., Sarig, R., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.125 · Cited by 56
Aulicino, F., Theka, I., Ombrato, L., Lluı́s, F., & Cosma, M. P. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.04.001 · Cited by 54
Zhou, R., Xu, A., Gingold, J. A., Strong, L. C., Zhao, R., & Lee, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.07.004 · Cited by 52
Ray, A., Joshi, J. M., Sundaravadivelu, P. K., Raina, K., Lenka, N., Kaveeshwar, V., & Thummer, R. P. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10200-3 · Cited by 56
Switching cell fate, ncRNAs coming to play
Guan, D., Zhang, W., Zhang, W., Liu, G.-H., & Belmonte, J. C. I. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.196 · Cited by 52
Bernhardt, M., Galach, M., Novak, D., & Utikal, J. S. (2012) · Biotechnology Journal · doi:10.1002/biot.201100347 · Cited by 55
Stimulation of Somatic Cell Reprogramming by ERas‐Akt‐FoxO1 Signaling Axis
Yu, Y. S., Liang, D., Tian, Q., Chen, X.-N., Jiang, B., Chou, B.-K., Hu, P., Cheng, L.-Z., Gao, P., Li, J., et al. (2014) · Stem Cells · doi:10.1002/stem.1447 · Cited by 49
Clinical Therapy Using iPSCs: Hopes and Challenges
Lu, X., & Zhao, T. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.002 · Cited by 52
Jiao, J., Dang, Y., Yang, Y., Gao, R., Zhang, Y., Kou, Z., Sun, X., & Gao, S. (2013) · Stem Cells · doi:10.1002/stem.1318 · Cited by 51
He, J., Kang, L., Wu, T., Zhang, J., Wang, H., Gao, H., Zhang, Y., Huang, B., Liu, W., Kou, Z., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0015 · Cited by 51
Metadata
- Authors
- Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S.
- Affiliations
- Kyoto University (JP)
- RIKEN (JP)
- Gladstone Institutes (US)
- Corresponding author
- Yamanaka, Shinya
- Venue
- Nature
- Published
- 2009-08
- Volume
- 460
- Issue
- 7259
- Pages
- 1132-1135
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2917235
- OpenAlex
- W2081620485
- Cited by
- 1,301
- References
- 23
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 25 · 2023: 29 · 2022: 44 · 2021: 51 · 2020: 41 · 2019: 56 · 2018: 63 · 2017: 59 · 2016: 78 · 2015: 88 · 2014: 116 · 2013: 117 · 2012: 168
- FWCI
- 67.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01HL100406)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, p53, p21, p53/p21 pathway, reprogramming efficiency, mouse embryonic fibroblasts, T cells, plasmid transfection, p53 target genes, tumorigenicity, Oct4, SOX2, KLF4, c-Myc
- MeSH terms
- Kruppel-Like Factor 4, Adult, Animals, Cell Differentiation, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Plasmids, T-Lymphocytes, Transfection, Tumor Suppressor Protein p53, Genes, myc, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
